Evaluation of glucagon-like peptide-1 receptor expression in non-diabetic and diabetic atherosclerotic mice using PET tracer (68)Ga-NODAGA-exendin-4
The procedure is relatively quick, often taking around 5 minutes
Not intended for human, veterinary or therapeutic use under any circumstances
GLP-1 Side Effects The use of GLP-1 receptor agonists, while beneficial for weight management, can sometimes come with side effects
The relatively small numbers (n = 1989) and the short duration of the study require caution, but the results appear highly promising while awaiting the results of ongoing studies (SURPASS-CVOT) [66]
And this was useful because you could ask, Well, why in the 70s didnt you just make this drug then if you knew about this? And the answer is that peptide chemistry wasnt very mature